| Human tribbles, a protein family controlling mitogen-activated protein kinase cascades E Kiss-Toth, SM Bagstaff, HY Sung, V Jozsa, C Dempsey, JC Caunt, ... Journal of Biological Chemistry 279 (41), 42703-42708, 2004 | 379 | 2004 |
| Virtual screening for β-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228 T Polgár, GM Keserü Journal of Medicinal Chemistry 48 (11), 3749-3755, 2005 | 113 | 2005 |
| Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3β inhibitors T Polgár, A Baki, GI Szendrei, GM Keserűu Journal of medicinal chemistry 48 (25), 7946-7959, 2005 | 93 | 2005 |
| Curcumin: total-scale analysis of the scientific literature AWK Yeung, M Horbańczuk, NT Tzvetkov, A Mocan, S Carradori, F Maggi, ... Molecules 24 (7), 1393, 2019 | 77 | 2019 |
| Integration of virtual and high throughput screening in lead discovery settings T Polgár, G M Keseru Combinatorial chemistry & high throughput screening 14 (10), 889-897, 2011 | 60 | 2011 |
| Ensemble docking into flexible active sites. critical evaluation of FlexE against JNK-3 and β-secretase T Polgár, GM Keserü Journal of chemical information and modeling 46 (4), 1795-1805, 2006 | 60 | 2006 |
| Functional mapping and identification of novel regulators for the Toll/Interleukin-1 signalling network by transcription expression cloning E Kiss-Toth, DH Wyllie, K Holland, L Marsden, V Jozsa, KM Oxley, ... Cellular signalling 18 (2), 202-214, 2006 | 59 | 2006 |
| Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening R Kiss, T Polgár, A Kirabo, J Sayyah, NC Figueroa, AF List, L Sokol, ... Bioorganic & medicinal chemistry letters 19 (13), 3598-3601, 2009 | 53 | 2009 |
| Screen3D: a novel fully flexible high-throughput shape-similarity search method A Kalaszi, D Szisz, G Imre, T Polgar Journal of chemical information and modeling 54 (4), 1036-1049, 2014 | 52 | 2014 |
| Impact of ligand protonation on virtual screening against β-secretase (BACE1) T Polgár, C Magyar, I Simon, GM Keserü Journal of chemical information and modeling 47 (6), 2366-2373, 2007 | 50 | 2007 |
| Synergistic effect of Avemar on proinflammatory cytokine production and Ras‐mediated cell activation A Telekes, E KISS‐TÓTH, T Nagy, EE Qwarnstrom, E Kusz, T Polgar, ... Annals of the New York Academy of Sciences 1051 (1), 515-528, 2005 | 31 | 2005 |
| Phytochemistry: An in-silico and in-vitro Update S Kumar, C Egbuna Springer Singapore, 2019 | 27 | 2019 |
| The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo A Kirabo, J Embury, R Kiss, T Polgár, M Gali, A Majumder, KS Bisht, ... Journal of Biological Chemistry 286 (6), 4280-4291, 2011 | 23 | 2011 |
| Structure-Function Correlation of G6, a Novel Small Molecule Inhibitor of Jak2: Indispensability of the Stilbenoid Core KBPPS Anurima Majumder, Lakshmanan Govindasamy, Andrew The FASEB journal 24, 620.5, 2010 | 21* | 2010 |
| Food toxicology: quantitative analysis of the research field literature AWK Yeung, NT Tzvetkov, A Jóźwik, OK Horbanczuk, T Polgar, ... International Journal of Food Sciences and Nutrition 71 (1), 13-21, 2020 | 18 | 2020 |
| Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets T Polgár, DK Menyhárd, GM Keserű Journal of Computer-Aided Molecular Design 21, 539-548, 2007 | 12 | 2007 |
| Functional mapping of Toll/interleukin-1 signalling networks by expression cloning E Kiss-Toth, DH Wyllie, K Holland, L Marsden, V Jozsa, KM Oxley, ... Biochemical Society Transactions 33 (6), 1405-1406, 2005 | 11 | 2005 |
| Structure-based virtual screening P Tímea, GM Keseru Frontiers in Drug Design and Discovery: Volume 3, 477-502, 2007 | 9 | 2007 |
| Functional virtual screening of estrogen receptor α modulators by FlexX-Pharm I Virág, T Polgár, GM Keserű Journal of Molecular Structure: THEOCHEM 725 (1-3), 239-242, 2005 | 7 | 2005 |
| Structure-based β-secretase (BACE1) inhibitors T Polgár, G M Keseru Current Pharmaceutical Design 20 (20), 3373-3379, 2014 | 6 | 2014 |
György M. KeserűHungarian Academy of SciencesEmail verificata su ttk.mta.hu